(304 days)
The HP M3000A/M3046A Compact Portable Patient Monitor is indicated for use in health care facilities by health care professionals when the patient's clinician deems it appropriate to use a device that:
- Can measure and display multiple physiological parameters and waves' of a) one patient, and can generate alarms and printouts based on those measurements.
- Can be used on adult, pediatric, and neonatal patients as specified in the b) Technical Data Sheets. The non-intrasive pressure can be used for adult and pediatric patients.
-
- List of supported measurements
- ECG (a)
- Respiration (b)
- Invasive blood pressure (c)
- Non-invasive blood pressure (d)
- SpO2 and Pleth (e)
- Temperature (f)
-
M3000A/M3046A Compact Portable Patient Monitor
Here's an analysis of the provided text regarding the acceptance criteria and study information for the Hewlett-Packard Models M3000A Multi-Measurement Server and M3046A Compact Portable Patient Monitor.
Based on the provided document, which is an FDA 510(k) clearance letter, there is no detailed information about the acceptance criteria or a specific study that proves the device meets these criteria in the manner expected for a typical AI/ML device submission.
This document is a 510(k) clearance letter from 1998 for a patient monitor, not an AI/ML diagnostic device. Therefore, the questions related to AI performance metrics, ground truth establishment, training sets, and expert adjudication are mostly not applicable to this type of device and submission.
The document primarily focuses on establishing "substantial equivalence" to a predicate device marketed before May 28, 1976. This is a regulatory pathway that doesn't typically require the detailed performance study data that would be relevant for an AI/ML device.
However, I will extract any relevant information that can be inferred from the text regarding the device's intended performance and "acceptance" in a regulatory context, and explicitly state what information is not present.
1. A table of acceptance criteria and the reported device performance
| Acceptance Criteria (Inferred) | Reported Device Performance | Comments |
|---|---|---|
| Regulatory Substantial Equivalence: | Device deemed "substantially equivalent" to predicate devices. | This is the primary "acceptance criterion" for a 510(k) submission. It means the device is as safe and effective as a legally marketed device. |
| Indications for Use: | Monitor physiological parameters and waves (ECG, Respiration, Invasive BP, Non-invasive BP, SpO2/Pleth, Temperature) for adult, pediatric, and neonatal patients. | The device's ability to measure these parameters as specified in Technical Data Sheets is implied. Specific performance metrics (e.g., accuracy, precision) are not detailed in this clearance letter. |
| Alarm Generation: | Device can generate alarms based on measurements. | Functionality is stated. No specific alarm sensitivity or specificity performance data is provided. |
| Printout Capability: | Device can generate printouts based on measurements. | Functionality is stated. |
| Patient Population: | Adult, pediatric, and neonatal patients (with non-invasive pressure for adult and pediatric only). | The device's applicability to these populations is cleared. Specific performance across these populations is not detailed here. |
| Clinical Environment: | Used in healthcare facilities by healthcare professionals. | This defines the intended use environment and user. |
2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
- Not Applicable/Not Provided. The 510(k) clearance letter does not describe a clinical performance test set, its sample size, or the provenance of data for specific performance evaluation in the way it would for an AI/ML device. The "test" for a traditional 510(k) is primarily a demonstration of equivalence to a predicate device, often through bench testing and review of existing predicate data, rather than a de novo clinical study with a dedicated test set.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
- Not Applicable/Not Provided. No mention of a test set requiring expert-established ground truth. This is not relevant for a patient monitor's 510(k) clearance.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
- Not Applicable/Not Provided. No test set or adjudication method is described.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- Not Applicable/Not Provided. This is a clearance for a patient monitor, not an AI-assisted diagnostic tool.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- Not Applicable/Not Provided. The device is a "Multi-Measurement Server and Compact Portable Patient Monitor," implying human users. It is not an algorithm-only device.
7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)
- Not Applicable/Not Provided. The concept of "ground truth" for diagnostic accuracy (as would be relevant for AI/ML) is not present in this document. The "ground truth" for a patient monitor would be the true physiological state, measured by gold-standard instruments, but such comparative validation details are not in this clearance letter.
8. The sample size for the training set
- Not Applicable/Not Provided. This device is a hardware patient monitor, not an AI/ML system that undergoes "training."
9. How the ground truth for the training set was established
- Not Applicable/Not Provided. Not an AI/ML device.
{0}------------------------------------------------
Image /page/0/Picture/10 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus, a symbol often associated with medicine and healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular pattern around the caduceus.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 2 3 1998
Mr. Egon Pfeil Hewlett-Packard GmbH Schickardstrasse 4 D-71034 Boeblingen Germany
Re: K971910 Hewlett-Packard Models M3000A Multi-Measurement Server and M3046A Compact Portable Patient Monitor Requlatory Class: III (three) Product Code: 74 DSI December 5, 1997 Dated: Received: December 12, 1997
Dear Mr. Pfeil:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Druq, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labelinq, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.
{1}------------------------------------------------
Page 2 - Mr. Egon Pfeil
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Thomas J. Callahan
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
510(k) Number (if known): K971910
Device Name: M3000A/M3046A Compact Portable Patient Monitor
Indications For Use:
The HP M3000A/M3046A Compact Portable Patient Monitor is indicated for use in health care facilities by health care professionals when the patient's clinician deems it appropriate to use a device that:
- Can measure and display multiple physiological parameters and waves' of a) one patient, and can generate alarms and printouts based on those measurements.
- Can be used on adult, pediatric, and neonatal patients as specified in the b) Technical Data Sheets. The non-intrasive pressure can be used for adult and pediatric patients.
-
- List of supported measurements
- ECG (a)
- Respiration (b)
- Invasive blood pressure (c)
- Non-invasive blood pressure (d)
- SpO2 and Pleth (e)
- Temperature (f)
-
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use: yes (Per 21 CFR 801,109)
OR
Over-The-Counter Use: no
3
(Optional Format 1-2-96)
. Praz
(Division Sign-Off) (Division of Cardiovascular, Respiratory, and Neurological Devices
510(k) Number _
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.